FSSAI Advisory On Raising Grievances Related To Central Licences’ Plea

New Delhi : The FSSAI has issued an advisory explaining the matrix for raising grievances/queries related to Central licences’ applications.

The advisory says that in case any food business operator (FBO) is aggrieved by the decision by the Central licensing authority, the matter can be escalated to the concerned Regional Director while in case the FBO further wants to represent the case after receiving comments from the concerned Regional Director or in case no comments was received within 21 days from raising the request to the concerned RD, the FBO can escalate the matter before Executive Director Compliance Strategy at FSSAI Headquarters along with all the relevant communication made with respect to the case till date.

The FSSAI has also advised that communication should be made through registered email id as provided in the licensing application by the FBO.

It is pertinent to note that FSSAI has an online platform, the Food Safety Compliance System (FoSCoS) for issuance of pan-India FSSAI licence and registration and for Central licensing procedures as laid down under the FSS Act, the food authority has approved Central Licensing Authority (CLA).

  • Related Posts

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Food regulator FSSAI on Friday said it has suspended the licence of Punjab-based Rehaan Healthcare after it found serious violations of rules at the company’s health supplements and nutraceuticals manufacturing…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun